Inovio Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018

    NEXT STORY
    Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009
    PREV STORY
    Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Mateon Announces Adjournment of Special Meeting of Stockholders

    SOUTH SAN FRANCISCO, Calif., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (Nasdaq:MATN), ...

    author_avatar
    NASDAQ Market News

    Veradigm™ Supports Cancer Experience Registry With Targeted Outreach Direct to Oncology Healthcare Professionals

    CHICAGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Veradigm™, an Allscripts (NASDAQ:MDRX), business unit and ...

    author_avatar
    NASDAQ Market News

    Selecta Biosciences Announces First Patient Dosed in Phase 1 Trial of SVP-Rapamycin and LMB-100 Combination Therapy in Mesothelioma

    WATERTOWN, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage ...

    author_avatar
    NASDAQ Market News